Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

287
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
287
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

730
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
730
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

329
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
329
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

416
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
416
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

328
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization tool.

Acta pharmaceutica Sinica. B·2026
Same author

NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice.

Science advances·2026
Same author

Pathophysiology, biological models and new therapeutic approaches in β-Propeller Associated Neurodegeneration.

International review of cell and molecular biology·2026
Same author

Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia.

Orphanet journal of rare diseases·2025
Same author

Mitochondrial Unfolded Protein Response (mtUPR) Activation Improves Pathological Alterations in Cellular Models of Ethylmalonic Encephalopathy.

Antioxidants (Basel, Switzerland)·2025
Same author

Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD).

British journal of pharmacology·2025

Related Experiment Video

Updated: Jan 5, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.7K

Atherosclerosis and Coenzyme Q10.

Juan M Suárez-Rivero1, Carmen J Pastor-Maldonado2, Mario de la Mata3

  • 1Centro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III, 41013 Sevilla, Spain. juasuariv@gmail.com.

International Journal of Molecular Sciences
|October 23, 2019
PubMed
Summary
This summary is machine-generated.

Coenzyme Q10 (CoQ10) may offer new therapeutic avenues for atherosclerosis by addressing cellular damage beyond lipid buildup. This molecule shows potential in reversing cellular alterations linked to atherosclerosis and aging.

Keywords:
agingatherosclerosiscoenzyme Q10ubiquinone

More Related Videos

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.9K
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

14.4K

Related Experiment Videos

Last Updated: Jan 5, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.7K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.9K
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

14.4K

Area of Science:

  • Cardiovascular Science
  • Biochemistry
  • Aging Research

Background:

  • Atherosclerosis is a leading cause of global cardiac mortality, traditionally viewed as arterial lipid deposition.
  • Cellular factors including inflammation, impaired autophagy, mitochondrial dysfunction, and oxidative stress significantly contribute to arterial damage.

Purpose of the Study:

  • To review the current understanding of coenzyme Q10 (CoQ10) in relation to atherosclerosis.
  • To explore CoQ10's potential as a therapeutic agent for atherosclerosis and age-related conditions.

Main Methods:

  • Literature review focusing on the molecular and cellular mechanisms of atherosclerosis.
  • Analysis of CoQ10's biochemical properties and their relevance to pathological pathways in atherosclerosis.
  • Exploration of the link between atherosclerosis, aging, and CoQ10 supplementation.

Main Results:

  • CoQ10 possesses multifunctional properties, including redox and signaling capabilities.
  • CoQ10 may counteract key cellular dysfunctions implicated in atherosclerosis, such as cholesterol biosynthesis issues, autophagy impairment, and mitochondrial dysfunction.
  • Atherosclerosis shares phenotypic similarities with aging, suggesting CoQ10 could benefit both.

Conclusions:

  • CoQ10 presents a promising therapeutic candidate for atherosclerosis due to its ability to address multiple cellular pathologies.
  • Supplementation with CoQ10 may hold potential benefits for managing both atherosclerosis and the aging process.